Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
DRI Healthcare (TSE:DHT.UN)
TSX:DHT.UN
Holding TSE:DHT.UN?
Track your performance easily
DHT.UN Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$10.39 - C$17.43
Previous CloseC$13.17
Volume157.81K
Average Volume (3M)36.98K
Market Cap
C$745.56M
Enterprise ValueC$1.06B
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$223.16M
Price to Earnings (P/E)44.9
Beta-0.07
Next Earnings
Feb 26, 2025EPS Estimate
C$0.8Last Dividend Ex-Date
Sep 27, 2024Dividend Yield3.36%
Share Statistics
EPS (TTM)0.29
Shares Outstanding56,385,882
10 Day Avg. Volume54,631
30 Day Avg. Volume36,981
Standard Deviation0.11
R-Squared0.04
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)1.41
Price to Sales (P/S)3.40
Price to Cash Flow (P/CF)4.80
P/FCF Ratio3.70
Enterprise Value/Market CapN/A
Enterprise Value/Revenue7.77
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$18.34Price Target Upside39.26% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Bulls Say, Bears Say
Bulls Say
Acquisition ImpactDRI Healthcare Trust's acquisition of a stream of fees from Editas Medicine related to Vertex Pharmaceuticals' sublicensing of Cas9 technology strengthens its portfolio with cutting-edge gene-editing royalties.
Analyst RecommendationAnalyst recommends a BUY for DRI Healthcare Trust with a target price of C$18.00, highlighting confidence in its strategic moves and potential growth.
Financial StrategyThe opportunity for DRI Healthcare Trust to revamp its fee and capital structure could attract wider investor interest by simplifying operations and potentially increasing returns.
Bears Say
Growth LimitationsThere is limited upside as the investigation continues, including from a likely pause in the pursuit of new royalty assets, where the sector is undergoing inflection.
Leadership InstabilityDRI announced the immediate resignation of its CEO and suspension of its CFO with pay as the result of an ongoing investigation related to irregularities associated with consulting fees and expenses by the previous CEO.
Market OpportunitiesThe investigation creates a substantial overhang and the pursuit of new royalty assets is likely to be paused, despite a unique opportunity in the market and inflection underway.
---
Options Prices
Currently, No data available
---
Ownership Overview
8.25% Insiders
0.02% Mutual Funds
― Other Institutional Investors
91.33% Public Companies and
Individual Investors
DHT.UN FAQ
What was DRI Healthcare’s price range in the past 12 months?
DRI Healthcare lowest stock price was C$10.39 and its highest was C$17.43 in the past 12 months.
What is DRI Healthcare’s market cap?
Currently, no data Available
When is DRI Healthcare’s upcoming earnings report date?
DRI Healthcare’s upcoming earnings report date is Feb 26, 2025 which is in 108 days.
How were DRI Healthcare’s earnings last quarter?
DRI Healthcare released its earnings results on Nov 06, 2024. The company reported C$0.624 earnings per share for the quarter, beating the consensus estimate of C$0.609 by C$0.015.
Is DRI Healthcare overvalued?
According to Wall Street analysts DRI Healthcare’s price is currently Undervalued.
Does DRI Healthcare pay dividends?
DRI Healthcare pays a Quarterly dividend of C$0.12 which represents an annual dividend yield of 3.36%. See more information on DRI Healthcare dividends here
What is DRI Healthcare’s EPS estimate?
DRI Healthcare’s EPS estimate is C$0.8.
How many shares outstanding does DRI Healthcare have?
DRI Healthcare has 56,268,820 shares outstanding.
What happened to DRI Healthcare’s price movement after its last earnings report?
DRI Healthcare reported an EPS of C$0.624 in its last earnings report, beating expectations of C$0.609. Following the earnings report the stock price went down -4.332%.
Which hedge fund is a major shareholder of DRI Healthcare?
Currently, no hedge funds are holding shares in TSE:DHT.UN
---
DRI Healthcare Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
C$18.34 (39.26% Upside)
C$18.34 (39.26% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
26.17%
12-Months-Change
Fundamentals
Return on Equity
2.27%
Trailing 12-Months
Asset Growth
8.86%
Trailing 12-Months
Company Description
DRI Healthcare
DRI Healthcare Trust is an open-ended trust that provides unitholders with differentiated exposure to the anticipated growth in the global pharmaceuticals and biotechnology markets. Its business model is focused on managing and growing a diversified portfolio of pharmaceutical royalties to deliver attractive growth in cash royalty receipts over the long term.
---
DHT.UN Stock 12 Month Forecast
Average Price Target
C$18.34
▲(39.26% Upside)
Technical Analysis
Best Analysts Covering DHT.UN
1 Year
1 Year Success Rate
13/21 ratings generated profit
1 Year Average Return
+29.06%
reiterated a buy rating 3 days ago
Copying Douglas Miehm's trades and holding each position for 1 Year would result in 61.90% of your transactions generating a profit, with an average return of +29.06% per trade.
---